Heart Transplant Rejection Breath Test Data Falls Short – CMS
This article was originally published in The Gray Sheet
Medicare coverage of a breathalyzer test to detect heart transplant rejection is not warranted based on the current level of supporting data, CMS says
You may also be interested in...
Medicare will not cover Menssana Research's Heartsbreath heart transplant rejection test, CMS said Dec. 8
3D-printing company Carbon and in vitro diagnostics maker Resolution Medical announced plans to manufacture more than one million 3D-printed nasal swabs per week to test for COVID-19. See what Resolution Medical’s president Shawn Patterson said about it here.